C. L. Raison, R. E. Rutherford, B. J. Woolwine, et al., «A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-resistant Depression: The Role of Baseline Inflammatory Biomarkers». JAMA Psychiatry 70 (2013): 31–41.
